195 related articles for article (PubMed ID: 34845846)
1. Clinical implications of retinal oximetry in retinal vein occlusion: a review.
Belamkar AV; Jabbehdari S; Harris A; Hajrasouliha AR
Acta Ophthalmol; 2022 Sep; 100(6):624-631. PubMed ID: 34845846
[TBL] [Abstract][Full Text] [Related]
2. Retinal oximetry during treatment of retinal vein occlusion by ranibizumab in patients with high blood pressure and dyslipidemia.
Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
J Fr Ophtalmol; 2016 Dec; 39(10):816-821. PubMed ID: 27865689
[TBL] [Abstract][Full Text] [Related]
3. Retinal oximetry.
Hardarson SH
Acta Ophthalmol; 2013 Mar; 91 Thesis 2():1-47. PubMed ID: 23470088
[TBL] [Abstract][Full Text] [Related]
4. Acute variations in retinal vascular oxygen content in a rabbit model of retinal venous occlusion.
Jaime GR; Kashani AH; Saati S; Martin G; Chader G; Humayun MS
PLoS One; 2012; 7(11):e50179. PubMed ID: 23185567
[TBL] [Abstract][Full Text] [Related]
5. Effects of Intravitreal Dexamethasone Implants on Retinal Oxygen Saturation, Vessel Diameter, and Retrobulbar Blood Flow Velocity in ME Secondary to RVO.
Eibenberger K; Schmetterer L; Rezar-Dreindl S; Wozniak P; Told R; Mylonas G; Krall C; Schmidt-Erfurth U; Sacu S
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5022-5029. PubMed ID: 28973374
[TBL] [Abstract][Full Text] [Related]
6. Retinal oximetry and systemic arterial oxygen levels.
Eliasdottir TS
Acta Ophthalmol; 2018 Nov; 96 Suppl A113():1-44. PubMed ID: 30460761
[TBL] [Abstract][Full Text] [Related]
7. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
[TBL] [Abstract][Full Text] [Related]
8. Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features.
Inagaki S; Shimazawa M; Otsu W; Araki T; Numata Y; Nakamura S; Tsusaki H; Hara H
Curr Neurovasc Res; 2021; 18(1):123-133. PubMed ID: 32867658
[TBL] [Abstract][Full Text] [Related]
9. RANIBIZUMAB FOR RETINAL VEIN OCCLUSION: Predictive Factors and Long-Term Outcomes in Real-Life Data.
Chatziralli I; Theodossiadis G; Chatzirallis A; Parikakis E; Mitropoulos P; Theodossiadis P
Retina; 2018 Mar; 38(3):559-568. PubMed ID: 28248827
[TBL] [Abstract][Full Text] [Related]
10. Retinal vascular oximetry during ranibizumab treatment of central retinal vein occlusion.
Traustason S; la Cour M; Larsen M
Br J Ophthalmol; 2014 Sep; 98(9):1208-11. PubMed ID: 24729079
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections.
Maggio E; Maraone G; Mete M; Vingolo EM; Grenga PL; Guerriero M; Pertile G
Acta Ophthalmol; 2021 Nov; 99(7):e1154-e1161. PubMed ID: 33421346
[TBL] [Abstract][Full Text] [Related]
12. Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion:
Pielen A; Feltgen N; Hattenbach LO; Hoerauf H; Bertelmann T; Quiering C; Vögeler J; Priglinger S; Lang GE; Schmitz-Valckenberg S; Wolf A; Rehak M
Curr Eye Res; 2020 May; 45(5):604-614. PubMed ID: 31665935
[No Abstract] [Full Text] [Related]
13. A narrative review on the association of high intraocular pressure and glaucoma in patients with retinal vein occlusion.
Jabbehdari S; Yazdanpanah G; Cantor LB; Hajrasouliha AR
Ann Transl Med; 2022 Oct; 10(19):1072. PubMed ID: 36330401
[TBL] [Abstract][Full Text] [Related]
14. Retinal vein occlusion in Armenia.
Malayan AS; Shakhsuvaryan ML; Grigoryan GL; Melkonyan AK
Eur J Ophthalmol; 1999; 9(3):196-201. PubMed ID: 10544974
[TBL] [Abstract][Full Text] [Related]
15. Impact of Intravitreal Ranibizumab on Vessel Functionality in Patients With Retinal Vein Occlusion.
Corvi F; La Spina C; Benatti L; Querques L; Lattanzio R; Bandello F; Querques G
Am J Ophthalmol; 2015 Jul; 160(1):45-52.e1. PubMed ID: 25896458
[TBL] [Abstract][Full Text] [Related]
16. Primary angle closure and primary angle closure glaucoma in retinal vein occlusion.
Xu K; Wu L; Ma Z; Liu Y; Qian F
Acta Ophthalmol; 2019 May; 97(3):e364-e372. PubMed ID: 30239140
[TBL] [Abstract][Full Text] [Related]
17. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
[TBL] [Abstract][Full Text] [Related]
18. Extension of peripheral nonperfusion in eyes with retinal vein occlusion during intravitreal dexamethasone treatment.
Rezar-Dreindl S; Eibenberger K; Buehl W; Weigert G; Georgopoulos M; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2018 Jun; 96(4):e455-e459. PubMed ID: 29485235
[TBL] [Abstract][Full Text] [Related]
19. Retinal oximetry does not predict 12-month visual outcome after anti-VEGF treatment for central retinal vein occlusion: A multicentre study.
Krejberg Jeppesen S; Sín M; Hakon Hardarson S; Bek T
Acta Ophthalmol; 2021 Nov; 99(7):e1141-e1145. PubMed ID: 33421320
[TBL] [Abstract][Full Text] [Related]
20. Poor outcomes despite aspirin or statin use in high-risk patients with retinal vein occlusion.
Matei VM; Xia JY; Nguyen C
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):761-766. PubMed ID: 28004197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
